January 09, 2020
Aprea Therapeutics to Present at the 38th Annual J.P. Morgan Healthcare Conference on Tuesday, January 14, 2020
Media
January 09, 2020
Strongbridge Biopharma plc Announces Preliminary Fourth Quarter and Full-Year 2019 Financial Results and Provides Update on Corporate Priorities
January 08, 2020
Targovax and IOVaxis Therapeutics enters Option Agreement for TG mutant RAS vaccine license and clinical development in China
January 07, 2020
Oncopeptides strengthens its regulatory function by appointing Karin Eklund Vanderpol as Head of Regulatory Affairs
December 20, 2019
GenSight Biologics obtains €15 million in financing through a bond issuance from Kreos Capital and a reserved capital increase from Sofinnova and 3SBio
December 18, 2019
BONESUPPORT appoints Kristina Ingvar to Executive Vice President Quality Management & Regulatory Affairs
December 18, 2019
Update on progress for drug development programs VP01 (C21) and VP02 (IMiD)
December 18, 2019
Nordic Nanovector awarded NOK 12 million in funding from the Norwegian Research Council to advance Alpha37, a targeted alpha therapy for B-cell cancers
December 17, 2019
Bulletin from the Extraordinary General Meeting in Oncopeptides AB (publ)
December 12, 2019
SVCA:s pris för Årets affär går till HealthCap VI LP för sin avyttring av Wilson Therapeutics AB
